Herbalife vs John B. Sanfilippo & Son
Weltweit tätiges Direktvertriebsunternehmen für Ernährung und Gewichtsmanagement vs US-amerikanischer Verarbeiter und Händler von Nüssen und Snacks. Welche Aktie passt im September 2026 besser zu Ihrem Portfolio? Die Antwort in einfacher Sprache finden Sie unten.
Herbalife sells nutritional supplements and weight management products through a multi-level marketing distribution network that's faced persistent regulatory scrutiny, while John B. Sanfilippo & Son processes and distributes nuts and snack products under the Fisher and Orchard Valley brands through conventional retail. Both companies compete in the nutrition and snacking space and manage complex supply chains for agricultural commodities. Herbalife vs John B. Sanfilippo & Son contrasts a controversial direct-sales model against a traditional branded food manufacturer to assess which delivers more reliable shareholder returns.
Herbalife sells nutritional supplements and weight management products through a multi-level marketing distribution network that's faced persistent regulatory scrutiny, while John B. Sanfilippo & Son ...
Anlageanalyse
Herbalife
HLF
Vorteile
- Herbalife operates globally in health and wellness, offering diversified products across multiple regions including North America, Europe, Asia, and Latin America.
- The company reported a substantial earnings growth of nearly 79% in 2024 despite a slight revenue decline, indicating improved profitability.
- Multiple analysts rate Herbalife as a strong buy with an average price target suggesting about 25% upside potential from current levels.
Zu beachten
- Herbalife's revenue experienced a marginal year-on-year decline of around 1.37% in 2024, highlighting challenges in top-line growth.
- The company’s return on equity (ROE) is negative on both 3- and 5-year averages, suggesting historical struggles with generating equity returns.
- There is some analyst disagreement, including bearish price forecasts and a strong sell rating from an AI analysis platform, indicating uncertainty in outlook.
Vorteile
- John B. Sanfilippo & Son is a diversified nut processor and distributor with multiple established private and branded product lines.
- The company has a track record of paying consistent dividends with a current yield around 1.29%, appealing to income-focused investors.
- JBSS serves varied distribution channels including retail, commercial users, and international clients, reducing customer concentration risk.
Zu beachten
- The stock has experienced a sharp year-to-date decline of approximately 20%, reflecting market or operational challenges.
- JBSS faces commodity price volatility risks as a processor of nuts, which could impact margins and earnings stability.
- The company’s exposure to highly competitive food and snack sectors may pressure pricing and necessitate continual product innovation.
HLF oder JBSS in Nemo kaufen
Ohne Provision
Handeln Sie Aktien, ETFs und mehr ohne Provision. Behalten Sie mehr von Ihrer Rendite.
Vertrauenswürdig & reguliert
Seit 2015 Teil der Exinity Group, mit über einer Million Kunden weltweit.
6 % Zinsen auf Guthaben
Erhalten Sie 6 % Zinsen p.a. auf nicht investiertes Guthaben, mit täglicher Zinsgutschrift.
